Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA:600222)
China · Delayed Price · Currency is CNY 7.63
-0.27 (-3.42%)
May 21, 2026, 3:00 PM CST
SHA:600222 Market Cap
SHA:600222 has a market cap or net worth of 4.37 billion as of May 21, 2026. Its market cap has increased by 53.81% in one year.
Market Cap
4.37B
Enterprise Value
5.22B
Revenue
1.78B
Ranking
n/a
PE Ratio
71.75
Stock Price
7.63
Market Cap Chart
Since January 2, 2001, SHA:600222's market cap has increased from 2.78B to 4.37B, an increase of 57.20%. That is a compound annual growth rate of 1.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 4.22B | 15.96% |
| Dec 31, 2025 | 3.64B | 28.87% |
| Dec 31, 2024 | 2.82B | -17.66% |
| Dec 29, 2023 | 3.43B | -3.25% |
| Dec 30, 2022 | 3.54B | -29.90% |
| Dec 31, 2021 | 5.06B | 84.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wuhan Hiteck Biological Pharma Co.,Ltd | 4.61B |
| Yabao Pharmaceutical Group | 4.56B |
| Bide Pharmatech | 4.48B |
| Jinhe Biotechnology CO., LTD. | 4.45B |
| Hainan Shuangcheng Pharmaceuticals | 4.34B |
| Newland Pharmaceutical | 4.28B |
| Tibet Weixinkang Medicine | 4.24B |
| Jinling Pharmaceutical Company | 4.22B |